Meridian Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Meridian Wealth Advisors's BMY Position: Q1 2024 in Review
Meridian Wealth Advisors sold out of Bristol-Myers Squibb (BMY) in Q1 2024, closing a stake of 4,050 shares — an estimated $208K sold.
Meridian Wealth Advisors first reported a position in BMY in Q4 2018 and held it in 18 quarters. The position peaked at $551K in Q2 2022. 2,332 funds tracked by Wall St. Rank hold BMY as of Q1 2024.
- Meridian Wealth Advisors reported no remaining Bristol-Myers Squibb position as of Q1 2024 after selling out during the quarter.
- Meridian Wealth Advisors sold 4,050 Bristol-Myers Squibb shares in Q1 2024, an estimated $208K.
- Meridian Wealth Advisors first reported a position in Bristol-Myers Squibb in Q4 2018 and held it in 18 quarters.
- Meridian Wealth Advisors's Bristol-Myers Squibb position peaked at $551K in Q2 2022.
- 2,332 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2024.
Based on Meridian Wealth Advisors's 13F filing for Q1 2024, filed 10 May 2024.